Cases

Court found that the JCC did not err in finding claimant's objection to the admissibility of evidence in accordance with the case of Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 US 579 as being untimely.  In addition, the JCC did not abuse her discretion in admitting expert testimony upon a finding that the experts were well acquainted with the claimant's medical history and medical condition, that they relied on published medical studies generally accepted within the medical community, and that they applied the results of these studies to the facts of the case in reaching their opinions on causation.